Skip to main content

Theratechnologies fera une présentation au H.C. Wainwright 4th Annual NASH Investor Conference le 5 octobre 2020

Written by Customer Service on . Posted in Public Companies.

MONTRÉAL, 30 sept. 2020 (GLOBE NEWSWIRE) — Theratechnologies inc. (« Theratechnologies ») (TSX: TH) (NASDAQ: THTX), une société biopharmaceutique commerciale axée sur le développement et la commercialisation de traitements innovateurs, a annoncé aujourd’hui que Dr Christian Marsolais, vice-président principal et chef de la direction médicale, fera une présentation au H.C. Wainwright 4thAnnual NASH Investor Conference le lundi 5 octobre 2020 à 16h30 (heure de l’Est).
La présentation de Dr Marsolais sera diffusée en direct par webdiffusion à l’adresse https://journey.ct.events/view/2ae02d3e-4e70-4522-bbba-b3fdb9b57e35. La webdiffusion archivée sera disponible une heure après la fin de l’évènement en direct.À propos de Theratechnologies
Theratechnologies (TSX : TH) (NASDAQ : THTX) est une société biopharmaceutique commerciale axée sur le développement et la commercialisation de traitements innovateurs qui répond à des besoins médicaux non satisfaits. D’autres renseignements sur Theratechnologies sont disponibles sur le site Web de la Société au www.theratech.com, sur SEDAR au www.sedar.com et sur EDGAR au www.sec.gov.Relations avec les médias :
Denis Boucher
Vice-président, communications et affaires corporatives
514-336-7800Relations avec les investisseurs:
Leah Gibson
Directrice principale, relations avec les investisseurs
617-356-1009

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.